NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Signals

etoro logo Buy CATB
*Your capital is at risk
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Latest Data & Signals Issued

Below are some of the latest signals issued for Catabasis Pharmaceuticals

General

Signal Type Signal Value Data
Score 0.000 194 days ( 61.82 %
Last Price $3.36 6.16 %
Performance History
7 Days
$3.38 $3.36
-0.592%
30 Days
$5.92 $3.36
-43.22%
12 Mos
$2.11 $3.36
59.24%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 19.23
Signal Type Signal Value Importance Data
High / Low Sell Very Low $3.16 - $3.37
Position: 95.24% from low / 4.76% from high · Momentum: -11.96%
Trend - 3 mos -38.47 % High Width: 96.45 %
Pred. range - 3 mos $1.65 - $3.24 Low -50.88 % - -3.50 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low May 24, 2022 - 4 days
RSI Short Pivot Signal Buy Very Low May 24, 2022 - 4 days
Short MA 3 mos Buy Low May 26, 2022 - 2 days
Long MA 3 mos Sell Medium Apr 08, 2022 - 35 days
Short/Long MA 3 mos Sell Medium Apr 08, 2022 - 35 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 59.84
Signal Type Signal Value Importance Data
Trend - 12 mos 30.20 % Very High Width: 284.99 %
Pred. range - 12 mos $4.10 - $15.79 High 22.04 % - 369.83 %
Short MA 12 mos Buy Very High Apr 29, 2022 - 21 days
Long MA 12 mos Buy Very High Apr 06, 2022 - 37 days
Short/Long MA 12 mos Sell Very High Jan 05, 2022 - 100 days
Pivot Long Buy Low May 24, 2022 - 4 days
RSI Long Pivot Signal Sell Low May 26, 2022 - 2 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CATABASIS PHARMACEUTICALS
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE